Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis

详细信息    查看全文

• 作者：Felix J. Hüttner ; Lutz Schneider ; Ignazio Tarantino…
• 关键词：Pancreatic neuroendocrine tumors ; Metastases ; Primary tumor resection ; Palliative ; Survival
• 刊名：Langenbeck's Archives of Surgery
• 出版年：2015
• 出版时间：August 2015
• 年：2015
• 卷：400
• 期：6
• 页码：715-723
• 全文大小：1,001 KB
• 参考文献：1.Fitzgerald TL, Hickner ZJ, Schmitz M, Kort EJ (2008) Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry. Pancreas 37(2):134-38CrossRef PubMed
  2.Modlin IM, Champaneria MC, Chan AK, Kidd M (2007) A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol 102(7):1464-473CrossRef PubMed
  3.Vagefi PA, Razo O, Deshpande V, McGrath DJ, Lauwers GY, Thayer SP, Warshaw AL, Fernandez-Del CC (2007) Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. Arch Surg 142(4):347-54PubMed Central CrossRef PubMed
  4.Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB (2008) One hundred years after “carcinoid- epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063-072CrossRef PubMed
  5.Halfdanarson TR, Rabe KG, Rubin J, Petersen GM (2008) Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol 19(10):1727-733PubMed Central CrossRef PubMed
  6.Metz DC, Jensen RT (2008) Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 135(5):1469-492PubMed Central CrossRef PubMed
  7.Chamberlain RS, Canes D, Brown KT, Saltz L, Jarnagin W, Fong Y, Blumgart LH (2000) Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190(4):432-45CrossRef PubMed
  8.Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA (1998) Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187(1):88-2, discussion 92- CrossRef PubMed
  9.House MG, Cameron JL, Lillemoe KD, Schulick RD, Choti MA, Hansel DE, Hruban RH, Maitra A, Yeo CJ (2006) Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer. J Gastrointest Surg 10(1):138-45CrossRef PubMed
  10.Sarmiento JM, Que FG, Grant CS, Thompson GB, Farnell MB, Nagorney DM (2002) Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. Surgery 132(6):976-82, discussion 982- CrossRef PubMed
  11.Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG (2003) Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 197(1):29-7CrossRef PubMed
  12.Bruzoni M, Parikh P, Celis R, Are C, Ly QP, Meza JL, Sasson AR (2009) Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor: a contemporary single-institution review. Am J Surg 197(3):376-81CrossRef PubMed
  13.Capurso G, Bettini R, Rinzivillo M, Boninsegna L, Delle FG, Falconi M (2011) Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review. Neuroendocrinology 93(4):223-29CrossRef PubMed
  14.Hill JS, McPhee JT, McDade TP, Zhou Z, Sullivan ME, Whalen GF, Tseng JF (2009) Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer 115(4):741-51CrossRef PubMed
  15.Falconi M, Bartsch DK, Eriksson B, Kloppel G, Lopes JM, O’Connor JM, Salazar R, Taal BG, Vullierme MP, O’Toole D, Barcelona Consensus Conference, Barcelona Consensus Conference p (2012) ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology 95(2):120-34CrossRef PubMed
  16.Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, Scoazec JY, Salazar R, Sauvanet A, Kianmanesh R, Barcelona Consensus Conference p (2012) ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology 95(2):98-19PubMed Central CrossRef PubMed
  17.Smith JK, Ng SC, Hill JS, Simons JP, Arous EJ, Shah SA, Tseng JF, McDade TP (2010) Complications after pancreatectomy for neuroendocrine tumors: a national study. J Surg Res 163(1):63-8CrossRef PubMed
  18.Bettini R, Mantovani W, Boninsegna L, Crippa S, Capelli P, Bassi C, Scarpa A, Pederzoli P, Falconi M (2009) Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. Dig Liver Dis 41(1):49-5CrossRef PubMed
  19.Wingo PA, Jamison PM, Hiatt RA, Weir HK, Gargiullo PM, Hutton M, Lee NC, Hall HI (2003) Building the infrastructure for nationwide cancer surveillance and control—a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control 14(2):175-93CrossRef PubMed
  20.Fritz A, Percy C, Jack A, Shanmugaratnam
• 作者单位：Felix J. Hüttner (1) (2)
  Lutz Schneider (1)
  Ignazio Tarantino (1)
  Rene Warschkow (3) (4)
  Bruno M. Schmied (3)
  Thilo Hackert (1)
  Markus K. Diener (1) (2)
  Markus W. Büchler (1)
  Alexis Ulrich (1)
  
  1. Department of General, Visceral, and Transplant Surgery, University of Heidelberg, Im Neuenheimer Feld 110, Heidelberg, 69120, Germany
  2. Study Center of the German Surgical Society, University of Heidelberg, Heidelberg, Germany
  3. Department of Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland
  4. Institute of Medical Biometry and Informatics, University of Heidelberg, Im Neuenheimer Feld 305, Heidelberg, 69120, Germany
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  General Surgery
  Abdominal Surgery
  Cardiac Surgery
  Thoracic Surgery
  Traumatic Surgery
  Vascular Surgery
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1435-2451

文摘

Purpose There is an ongoing debate on whether palliative removal of the primary tumor may result in a survival benefit for patients with incurable stage IV pancreatic neuroendocrine tumors (P-NET). The objective of this study was to assess whether palliative resection of the primary tumor in patients with incurable stage IV P-NET has an impact on survival.